Literature DB >> 2881076

Monoclonal marker that predicts early recurrence of breast cancer.

S H Dairkee, B H Mayall, H S Smith, A J Hackett.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 2881076     DOI： 10.1016/s0140-6736(87)92129-5

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  15 in total

1.  Expression of cytokeratins 17 and 5 identifies a group of breast carcinomas with poor clinical outcome.

Authors:  Matt van de Rijn; Charles M Perou; Rob Tibshirani; Phillippe Haas; Olli Kallioniemi; Juha Kononen; Joachim Torhorst; Guido Sauter; Markus Zuber; Ossi R Köchli; Frank Mross; Holger Dieterich; Rob Seitz; Doug Ross; David Botstein; Pat Brown
Journal:  Am J Pathol       Date:  2002-12       Impact factor: 4.307

Review 2.  AACR centennial series: the biology of cancer metastasis: historical perspective.

Authors:  James E Talmadge; Isaiah J Fidler
Journal:  Cancer Res       Date:  2010-07-07       Impact factor: 12.701

3.  Is the small heat shock protein alphaB-crystallin an oncogene?

Authors:  Sofia K Gruvberger-Saal; Ramon Parsons
Journal:  J Clin Invest       Date:  2006-01       Impact factor: 14.808

4.  [Basal and myoepithelial phenotype of metastatic mammary carcinomas. A prognostic factor in the palliative situation?].

Authors:  P Mainka; S Kahlert; T Kirchner; D Mayr; J Diebold
Journal:  Pathologe       Date:  2008-11       Impact factor: 1.011

Review 5.  BRCA1 and BRCA2: chemosensitivity, treatment outcomes and prognosis.

Authors:  William D Foulkes
Journal:  Fam Cancer       Date:  2006       Impact factor: 2.375

6.  Immunolocalization of a human basal epithelium specific keratin in benign and malignant breast disease.

Authors:  S H Dairkee; B M Ljung; H Smith; A Hackett
Journal:  Breast Cancer Res Treat       Date:  1987-10       Impact factor: 4.872

7.  Value of cytokeratin 5/6 immunostaining using D5/16 B4 antibody in the spectrum of proliferative intraepithelial lesions of the breast. A comparative study with 34betaE12 antibody.

Authors:  Magali Lacroix-Triki; Eliane Mery; Jean-Jacques Voigt; Luc Istier; Philippe Rochaix
Journal:  Virchows Arch       Date:  2003-04-24       Impact factor: 4.064

Review 8.  Do 'basal-like' breast cancers really exist?

Authors:  Barry Gusterson
Journal:  Nat Rev Cancer       Date:  2008-12-29       Impact factor: 60.716

9.  Statistical association of basal cell keratins with metastasis-inducing proteins in a prognostically unfavorable group of sporadic breast cancers.

Authors:  Suzete de Silva Rudland; Angela Platt-Higgins; John H R Winstanley; Nigel J Jones; Roger Barraclough; Christopher West; Joseph Carroll; Philip S Rudland
Journal:  Am J Pathol       Date:  2011-06-14       Impact factor: 4.307

10.  Basal cytokeratin as a potential marker of low risk of invasion in ductal carcinoma in situ.

Authors:  Fernando N Aguiar; Henrique N Mendes; Cinthya S Cirqueira; Carlos E Bacchi; Filomena M Carvalho
Journal:  Clinics (Sao Paulo)       Date:  2013-05       Impact factor: 2.365
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.